Prof. Dr. Hans-Eric Rasmussen-Bonne/Weitnauer has provided legal advice to the innovative medical technology startup Sedivention on its successful seed financing round. The company develops innovative solutions for the minimally invasive, interventional treatment of obesity and aims to improve the quality of life of patients worldwide. The financing round was led by High-Tech Gründerfonds (HTGF) and comprises a total volume of EUR 0.8 million, which will be used for the further development and market launch of the groundbreaking technology for the treatment of obesity.

Berater: Prof. Dr. Hans-Eric Rasmussen-Bonne, LL.M. (Partner)